Skip to main content
Caplight Logo









QurieGen

QurieGen

Private
NijmegenHealthcare & Life Scienceshttps://www.quriegen.com/

Last Round

Pre Seed

Apr 8, 2025

Total Funding Raised

$2.63M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

QurieGen is a biotechnology company that provides an AI-powered drug discovery platform integrating single-cell genomics and multi-omics to map cellular responses and accelerate therapeutic development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoverytechbiosingle-cell analysisoncology researchpredictive modelingmulti-omicslab-in-the-loopdrug target identificationai drug discoveryprecision medicinecellular signalingin silico drug discoverybiotech r&ddrug efficacy predictiondata as a service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

QurieGen Comparables

Compare QurieGen with similar companies based on industry and business-model similarity.

QurieGen comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cellyrix Therapeutics
85%
Scailyte AG
81%
Cellarity
78%

QurieGen Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedApr 8, 2025
GrantApr 8, 2025
GrantDec 11, 2024

Key People

Founding team and executive leadership

eng Kinga Matuła

Chief Executive Officer

Executive Team

Maciej Jarzab

Investor, Ex-Chief Operating Officer

Executive Team

QurieGen Investors

Notable investors and investment history

QurieGen investors
InvestorRounds
DIANAGrant
Lighthouse VenturesPre Seed
Draper AssociatesPre Seed
Moondust VenturesPre Seed
Tensor VenturesPre Seed
BSV VenturesPre Seed
22 Hor InvestPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 660% MoM, reaching 623.

  • May 25, 2025

    Added Cilag, S.A. from the Pharmaceuticals industry.

QurieGen Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

QurieGen Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about QurieGen's valuation, stock price, and market status.

Firmographic Details

HeadquartersNijmegen
Employee Range9
Year Founded2022
Last FundingApr 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?